Masimo (NASDAQ: MASI) will release fourth quarter and full year 2025 financial results for the period ended January 3, 2026, after the market closes on Thursday, February 26, 2026. The conference call ...
Zacks Investment Research on MSN
Here's why you should add Masimo stock to your portfolio now
Masimo Corporation MASI is well-poised for growth in the coming quarters, courtesy of its strong underlying demand for ...
Masimo activist Politan responded to a settlement offer from the company with one of its own: expand Masimo's board to seven directors and add Politan's two nominees. Politan's Quentin Koffey launched ...
Medical device company Masimo took the unusual step of subpoenaing Glass Lewis and ISS for their private communications with shareholders about Masimo's upcoming proxy fight with activist investor ...
Zacks Investment Research on MSN
Owlet vs. Masimo: Which medical monitoring stock is the better buy?
Remote and continuous patient monitoring is moving from a niche capability to a core pillar of modern healthcare, driven by aging populations, staffing shortages, and a push toward data-driven care ...
(Reuters) -Masimo said on Monday a potential joint venture partner is prepared to offer $850 million to $950 million for its consumer business, which includes health and audio products. Masimo and the ...
(Reuters) -Masimo said on Wednesday founder Joe Kiani has decided to step down as the medical device maker's CEO, days after shareholders voted to remove him from the company's board following a ...
Way back in 2013, Apple reportedly contacted medical tech company Masimo, as it was interested in forming a “working relationship” with the company. Following meetings in which details of Masimo’s ...
Masimo CEO shared confidential information with investor ahead of public release, court filing shows
Masimo CEO Joe Kiani, whose medical-technology company is in the midst of a proxy battle with activist Politan, revealed what he called confidential information to a major investor 12 hours before it ...
A federal jury Friday ruled that Masimo's smartwatches infringed on Apple Watch patents, but awarded Apple just $250 in damages, which is the statuary minimum amount Apple could seek while it pursues ...
Apple on Thursday began selling revised models of the Apple Watch Series 9 and Ultra 2 in the US without the blood oxygen feature as the company faces a patent dispute with medical company Masimo. In ...
Masimo (Nasdaq: MASI) is a global technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results